UAE surrogacy: clinics, agencies, contracts and payments
Short answer: the clearest current route is in Abu Dhabi
As of 25 October 2026, do not treat “surrogacy is legal in the UAE” as a complete answer. Federal Decree-Law No. 17 of 2023 amended Federal Law No. 7 of 2019 and removed the former express federal prohibition on a particular embryo-transfer arrangement. It did not create a single, comprehensive UAE-wide code for surrogacy contracts, payments, parentage and disputes.
The clearest current official route identified is Abu Dhabi: the Department of Health (DoH) Standard for Gestational Surrogacy, document DOH/STD/GS/HFS-HWS/V1/2025, version V2, published in December 2025 and effective from April 2026. It applies to DoH-designated licensed hospitals and assisted-reproduction clinics. The Abu Dhabi standard applies to the facilities it designates. Before treatment in Dubai or another emirate, confirm the applicable local rules. This does not mean that no local rule exists. Clinical access and later contract enforceability are separate questions.
Federal law: what changed and what still matters
Article 9 of the amended 2019 law prohibits specified third-party gamete combinations: sperm from a husband with an ovum from a woman other than his wife, and an ovum from a wife with sperm from a man other than her husband; it also permits the Cabinet to specify further prohibited cases. The Abu Dhabi DoH standard and consent form are narrower still: only the intended couple’s own eggs, sperm and embryo are allowed; donor eggs, donor sperm and donated embryos are not allowed under that pathway.
Article 8(1) imposes clinical, consent and documentation controls for assisted reproduction. Article 8(2) provides a separate application route for non-Muslim concerned persons without a marriage certificate. The declaration attributing the child’s lineage to either person must be certified by the competent authority in the country of nationality of the relevant party from which the child is to acquire citizenship, using the prescribed form. Do not assume that this general ART route automatically answers every surrogacy eligibility question. The current DoH standard uses “spouses”; obtain a written answer from DoH and the designated clinic about your exact status before paying.
Separately, Article 14 prohibits ART centres from using unfertilised or fertilised eggs and frozen sperm for commercial purposes or disposing of them to third parties. This rule concerns reproductive material and does not, by itself, settle whether every agency fee, expense reimbursement or proposed payment to a surrogate is lawful or enforceable. Published UAE law does not settle every payment structure; obtain specific written advice before transferring money.
Intended-parent eligibility is medically limited
Under the current DoH Standard V2, the female spouse (intended mother) must be 18–47 and be deemed mentally and physically capable of raising a child after assessment by healthcare providers. The standard separately requires medical and psychological evaluations of both spouses. The intended mother must have a qualifying medical reason for not carrying a pregnancy: a uterine disorder making implantation impossible (examples include congenital absence of the uterus or vagina or Asherman’s syndrome); repeated implantation failure or recurrent pregnancy loss, subject to committee approval; or a serious medical condition that puts the mother or fetus at risk of death.
Other conditions outside the listed categories are for the DoH medical committee to consider, not a self-approved exception. The standard also says the spouses should not have a disease transmissible to their offspring. Expect the facility to request medical history, investigations, specialist reports and psychological assessments. Age alone, personal preference or an agency’s assurance is not a substitute for medical necessity and formal approval.
Surrogate eligibility is also controlled
The surrogate must be 21–45, have a BMI of 19–30, and have had at least one previous pregnancy but no more than four previous births. She must not have had more than two previous caesarean sections and must meet the standard’s uterine-health condition, including absence of an isthmocele.
The facility must assess physical and mental health, the reproductive system and general fitness for pregnancy. The standard also excludes unsafe pregnancy medication, a history of illicit drug use or alcoholism, and medical conditions that could interfere with pregnancy. These are clinical criteria, not suggestions that an agency can waive. Ask the clinic to confirm each criterion in writing and explain how it will document the assessment.
Follow the approval sequence before the first medical procedure
Follow the DoH pathway; do not let an agency reverse it by asking for a large non-refundable payment first. The official workflow places eligibility assessment, DoH committee review, surrogate selection, notarised documents and final validation before the clinical programme begins.
- Confirm that the hospital and ART clinic are designated and licensed for this service. Ask for written confirmation of the exact service scope.
- The facility assesses the intended parents, including medical and psychological evaluation, and prepares the medical report. The DoH standard describes the report submitted to the committee as signed by two consultants; ask the facility to confirm in writing that the file meets this requirement.
- The facility submits the case to the DoH Medical Committee for Gestational Surrogacy, which decides medical necessity and eligibility. If approval is refused or not issued, do not proceed on an agency promise.
- After approval, the facility arranges selection of a surrogate through an approved agency; the surrogate is independently medically and psychologically assessed.
- All required consents and the legal agreement are signed and notarised by a Notary Public.
- The final signed documents return to the committee for review and validation.
- Only then should the clinic initiate treatment. The DoH Standard V2 states that PGT-A is mandatory for embryos and that only single-embryo transfers are allowed. It also states that PGT-M/SR is to be performed based on sequencing results (WES/karyotyping). Ask the facility to document the applicable test plan and protocol in writing, and do not rely on summaries of superseded V1. The workflow says the intended parent(s) and surrogate should be physically present on the birth date and that the birth certificate is issued based on the legal agreement.
The agreement and consent must be completed before treatment
The DoH standard requires a legal agreement consistent with applicable law and executive regulations, notarised by a Notary Public. The prescribed consent pathway includes the intended spouses and the surrogate; the official form also requires the surrogate’s husband’s consent if she is still married to him. Ask the designated facility or DoH to confirm in writing how the requirement applies to the parties’ exact circumstances. The surrogate must receive information about the risks, success rates and procedure before written consent; the facility must ensure all parties understand the medical, legal and emotional implications.
The official consent form describes the intended parents as the genetic parents and states that they are to be named mother and father on the birth certificate; it also records the surrogate’s and, if applicable, her husband’s waiver of parental claims. Treat this as part of the Abu Dhabi clinical pathway, not a universal guarantee that every court or foreign authority will accept parentage in every case. Notarisation and committee validation do not replace independent advice on enforceability and remedies.
Have counsel review the agreement for the parties and identity documents; scope of services; medical decision-making and consent; care and insurance; permitted expenses; timing and milestones; failed cycles and refunds; miscarriage or complications; unexpected costs; confidentiality and records; termination or incapacity; disputes and applicable forum; language, translations and copies. These are recommended review points, not a claim that the standard mandates every clause. Do not include terms that purport to compel a medical decision or waive mandatory rights.
Payments, insurance and agencies: do not infer permission from a price quote
The official materials do not provide a verified general tariff for agency fees or a clear, universal cap on surrogate compensation. This absence should not be turned into either “all commercial payments are lawful” or “all payments are criminal”. The standard expressly requires the intended parents to obtain insurance covering necessary surrogacy-related health services and to pay costs that the policy excludes or that exceed its limit. It says Thiqa, Basic, Enhanced insurance or another government-funded programme may not be used to cover surrogacy-related costs or complications to the surrogate’s health.
Separate the clinic’s treatment fees, agency service fee, legal/notary charges, insurance premium, reimbursed expenses and any payment proposed for the surrogate. Require a signed, itemised budget, the legal name and licence/status of each provider, invoices, a recipient bank account matching the contracting entity, milestones, cancellation/refund rules and the treatment of unused funds. Avoid cash, personal accounts, undocumented “facilitation” fees, guarantees of pregnancy or birth, and pressure to sign immediately. Ask DoH and independent UAE counsel to confirm the payment structure in writing before transfer.
Risk matrix: claims to verify before signing
Use this matrix to separate a marketing statement from a requirement that can be checked against official documents.
| Representation or issue | What the reviewed material establishes | Safer response |
|---|---|---|
| “Surrogacy is available throughout the UAE.” | Ask the health regulator in the intended emirate for written confirmation. | |
| “Our clinic and agency are approved.” | The DoH workflow uses designated facilities and approved agencies, with committee approval and validation. | Verify the facility’s licence/scope and the agency’s approval directly with the clinic and DoH. |
| “A donor or embryo from another person can be used.” | Third-party eggs, sperm and embryos are not allowed under the Abu Dhabi pathway described in the official standard/consent material. | Do not transfer money for a donor-based plan under this pathway; seek written legal and clinical confirmation. |
| “The package price proves the payment is legal.” | No universal official agency-fee tariff or surrogate-compensation cap was verified in the materials; insurance obligations are explicit. | Demand itemised costs, insurance terms, refund rules and independent advice on each payment category. |
| “Notarisation guarantees every legal outcome.” | Notarisation and DoH validation are part of the local pathway, but do not answer every later contract dispute or foreign-recognition question. | Obtain independent UAE legal advice and separate advice for each destination country. |
| “The birth certificate guarantees citizenship and travel.” | The DoH workflow links the birth certificate to the agreement; citizenship, passport and foreign recognition are separate questions. | Confirm nationality, passport, exit and re-entry requirements with the relevant authorities before treatment. |
| “The clinic proposes multiple-embryo transfer or omits PGT-A.” | DoH V2 states that PGT-A is mandatory and only single-embryo transfers are allowed; PGT-M/SR depends on WES/karyotyping results. | Pause treatment planning and obtain written confirmation of the protocol from the designated facility. |
Pre-payment checklist
Obtain and retain the following before any non-refundable commitment:
- The current V2 standard and written confirmation that it applies to the proposed facility and service.
- Written clinical protocol confirming mandatory PGT-A, single-embryo transfer, and any PGT-M/SR testing indicated by WES/karyotyping results.
- The facility’s licence and service scope, plus confirmation that the agency is approved for this pathway.
- The written eligibility assessment and DoH committee decision; do not treat a screenshot or an agency promise as approval.
- The complete agreement for independent UAE counsel to review before notarisation, and every consent form in a language each party understands.
- A cost schedule separating medical fees, agency fees, legal/notary charges, insurance and surrogate-related expenses, plus clear cancellation and refund rules.
- The insurance policy wording, exclusions and proof that no prohibited government-funded coverage is being used.
- Written rules for unsuccessful cycles, complications, extra treatment and unused funds; keep receipts, approvals, reports and communications.
- Nationality-specific advice on parentage, birth registration, citizenship, passport, travel documents and exit/re-entry.
Contact the regulator and facility using contact details on their official websites, not only details supplied by the intermediary.
If there is a refusal, dispute or cross-border problem
If a facility refuses approval or a dispute arises, request a written decision or explanation, preserve the signed agreement, consent forms, medical records, invoices, bank records, messages and approvals, and consult UAE counsel about the correct regulatory complaint or court route. UAE law sets no single published appeal deadline or remedy for every type of refusal or contractual dispute, so do not rely on an assumed deadline or a generic arbitration clause. Medical negligence, regulatory non-compliance, refund claims and contractual breach may require different procedures.
For international intended parents, resolve the separate home-country questions before treatment: recognition of parentage, birth registration, citizenship, passport, travel document and permission to leave the UAE. The DoH birth-certificate workflow does not itself establish that another state must recognise the parentage or grant citizenship. Obtain advice from the relevant embassy and a lawyer in the country where recognition will be sought.
Practical conclusion and limits of this guide
The current official route identified is an approval-led Abu Dhabi clinical pathway, not a free market in surrogacy services across the UAE. The contract must be notarised and the DoH committee must validate the documents before treatment; the own-gametes restriction and surrogate eligibility criteria are central. Payment permissibility and enforceability questions remain too important to infer from advertising or notarisation alone. Keep the agency out of the role of legal authority: obtain independent legal advice and written regulator/facility confirmation before any non-refundable commitment.
This guide relies on official material identified as at 25 October 2026.
Official sources
The links below are official source material. The federal 2019 law must be read with the 2023 amendment. Some official PDF content was available through indexed excerpts, but the full current DoH standard still requires a human clause-by-clause check.
- [S1] Federal Law No. (7) of 2019 Concerning Medically Assisted Reproduction — UAE Legislation portal. Original federal ART law; read with the 2023 amending decree, not in isolation.
- [S2] Federal Decree-Law No. (17) of 2023 amending Federal Law No. (7) of 2019 — Ministry of Health and Prevention. Official page for the federal amendment to the 2019 ART law.
- [S3] DoH Standard for Gestational Surrogacy (Full Surrogacy), V2 — Department of Health, Abu Dhabi. Current DoH Abu Dhabi standard identified as version V2, published December 2025 and effective April 2026.
- [S4] Assisted Reproduction Services and Technologies in Abu Dhabi — Department of Health. Official DoH programme information; not a substitute for case-specific facility or agency confirmation.
